CHPA Elects Board Directors and Officers at 2017 Annual Executive Conference

Washington, D.C. (March 22, 2017) – The Consumer Healthcare Products Association (CHPA) elected members and officers to its board of directors at the association’s Annual Executive Conference (AEC), held March 19-22, 2017, at The Ritz-Carlton, Amelia Island, Florida. Jeffrey R. Needham, executive vice president & president, U.S. consumer healthcare at Perrigo Company, will continue to serve as the association’s board chairman.

“CHPA benefits from a highly engaged board of directors, led by its chair, Jeff Needham,” says Scott Melville, CHPA’s president and CEO. “The board members provide steady leadership and strategic direction during what are challenging times for healthcare in America.” 

One-third of the CHPA Board of Directors is elected annually, with manufacturer members elected for three-year terms, and associate members elected for two-year terms. The board members re-elected at this meeting include: 

  • Christopher B. Ascher, co-president, B.F. Ascher & Company, Inc.;
  • Natalie Bartner, president, Consumer Health, North America, Bayer Consumer Health;
  • J.P. Borneman, Ph.D., chairman & chief executive officer, Hyland’s, Inc.;
  • Janick Boudazin, president & chief executive officer, Boiron Inc.;
  • Michael J. Donnantuono, president & chief operating officer, Blistex Inc.;
  • Scott R. Emerson, partner, DSE Healthcare Solutions, LLC;
  • Thomas M. Finn, president, Global HealthCare, The Procter & Gamble Company;
  • Stephen Fritz, head of OTC business, Purdue Pharma L.P.;
  • Jeffery H. Gerchenson, chairman & chief executive officer, Alva-Amco Pharmacal Companies, Inc.;
  • Joseph F. Gordon, general manager, Valeant Consumer Health Care;
  • John C. Incledon, president & chief executive officer, Hisamitsu America, Inc., Hisamitsu Pharmaceutical Co., Inc.;
  • Milan K. Kalawadia, vice president, head of U.S. OTC division, Dr. Reddy’s Laboratories, Inc.;
  • Robert Long, CPA, chief executive officer/head of CHC North America, Chattem, Inc.;
  • Wendy Shusko, chief executive officer, WellSpring Pharmaceutical Corporation;
  • Akiyoshi Yoshida, Ph.D., president & chief executive officer, The Mentholatum Company; and,
  • Richard Zulman, chief executive officer, BestCo, Inc.

The board members newly elected at this meeting include:

  • Agustin R. Caceres, president, North America, Genomma Lab USA Inc.;
  • Peter Caldini, regional president, North America, Pfizer Consumer Healthcare;
  • Sharon Glass, senior vice president, brand development, Catalina;
  • Avani Kanubaddi, chief executive officer, Welmedix Consumer Healthcare;
  • Mike Rosenberg, senior vice president, national advertising, Healthgrades, Inc.;
  • Rich Simonson, chief operating officer, Carma Laboratories, Inc.; and
  • Jeffrey Vernimb, general manager, North America, Moberg Pharma North America LLC.    

View the full CHPA Board of Directors. 


The Consumer Healthcare Products Association (CHPA) is the 136-year-old national trade association representing the leading manufacturers and marketers of over-the-counter (OTC) medicines and dietary supplements. Every dollar spent by consumers on OTC medicines saves the U.S. healthcare system $6-$7, contributing a total of $102 billion in savings each year. CHPA is committed to empowering self-care by preserving and expanding choice and availability of consumer healthcare products.

Lauren Bloomberg (